Therapy News and Research

RSS

TAILORED-Treatment project to increase effectiveness of antibiotics receives EU funding

The European Union has funded a 4 year project called TAILORED-Treatment with € 6.000.000,-. The main goal of TAILORED -Treatment is to establish a strategy that can be used to increase the effectiveness of antibiotic treatment, reduce any potential side-effects of therapy, and help limit the emergence of antimicrobial resistance in hospitalized children and adults. The project will be coordinated by Erasmus MC, Rotterdam, the Netherlands.

14 Nov 2013

Cedars-Sinai Phase I-II clinical trial may help combat recurrence of small cell lung cancer

Alain C. Mita, MD, is fighting an uphill battle against small cell lung cancer. Despite the severity of the disease, the standard-of-care treatment remains the same today as it was nearly 30 years ago.

14 Nov 2013

Will Healthcare.gov troubles slow Medicaid expansion too?

Medicaid sign-ups, part of the health law working the way many officials thought it should, could also be hurt by technological malfunctions. But one state is finding the opposite to be true. In the meantime, states consider new Medicaid expansions or report on how many new Medicaid enrollees are signing up.

14 Nov 2013

Hormone therapy does not help menopausal women who do not have hot flashes

Hormones at menopause can help with sleep, memory, and more, but only when a woman also has hot flashes, find researchers at Helsinki University in Finland. Their study was published online today in Menopause, the journal of The North American Menopause Society (NAMS).

14 Nov 2013

Polymer for mending broken bones holds hope for delivering chemotherapy drugs to the brain

A polymer originally designed to help mend broken bones could be successful in delivering chemotherapy drugs directly to the brains of patients suffering from brain tumours, researchers at The University of Nottingham have discovered.

14 Nov 2013

Mount Sinai researchers successfully test SUMO-1 gene therapy to reverse heart failure

Researchers at the Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai have successfully tested a powerful gene therapy, delivered directly into the heart, to reverse heart failure in large animal models.

14 Nov 2013

High-power blue laser gadgets can cause serious eye damage

A type of high-power blue laser toy readily available over the Internet and increasingly popular among male teens and young adults can cause serious, sometimes irreversible, eye damage, according to a report by investigators from Saudi Arabia’s King Khaled Eye Specialist Hospital and Johns Hopkins Medicine.

14 Nov 2013

Study shows that geranylgeraniol suppresses viability of human DU145 prostate carcinoma cells

Researchers at Texas Woman's University have shown that a diterpene geranylgeraniol found in linseed oil, Cedrela toona wood oil, sucupira branca fruit oil and more recently, annatto seed oil, suppressed the viability of human DU145 prostate carcinoma cells via cell cycle arrest at the G1 phase and the initiation of apoptosis.

14 Nov 2013

OvaScience reports net loss of $6.9 million in Q3 2013

OvaScienceSM, a life sciences company focused on the discovery, development and commercialization of new treatments for infertility, today reported financial results for the quarter ended September 30, 2013, as well as recent highlights.

14 Nov 2013

Imbruvica gets FDA approval for treatment of mantle cell lymphoma

The U.S. Food and Drug Administration today approved Imbruvica (ibrutinib) to treat patients with mantle cell lymphoma, a rare and aggressive type of blood cancer.

13 Nov 2013

TopPac® 20 ml prefillable polymer syringe for infusion therapy introduced by SCHOTT

SCHOTT expanded its range of TopPac polymer syringes to include a 20 milliliter (ml) format that can be used in combination with syringe pumps for infusion therapy. SCHOTT TopPac® prefillable syringes (PFS) simplify the infusion therapy preparation process and can ultimately reduce costs for pharmaceutical companies and health care facilities.

13 Nov 2013

Tailored doses of pre-transplant drug therapy in Glaucomatous patients boosts survival rates to over 90%

Chronic Granulomatous Disease is a rare immune deficiency that seriously compromises organ function and is life-threatening, with 20-30 per cent of patients dying within the first two decades of life.

13 Nov 2013

Welch Allyn, Cerner to deliver connected solution for patient data management

Welch Allyn, a leading medical diagnostic device company that specializes in helping clinicians improve patient outcomes, and Cerner Corporation, a company dedicated to contributing to the systemic change of health and care delivery, have collaborated to deliver a connected solution that can help clinicians overcome common issues like inaccuracy, poor data management and inefficient workflow.

13 Nov 2013

New biomedical instrument anticipated to help breakthroughs in animal, human health

A Kansas State University team recently received a nearly $1.3 million grant from the National Science Foundation's Major Research Institute for a biomedical instrument that is anticipated to help with breakthroughs in animal and human health as well as cancer treatment.

13 Nov 2013

Professor receives NOK 75M grant to develop idea for next generation personalized cancer therapy

Extensive statistical analyses of the mutation distribution in several thousand cancerous tumours make it possible to find cures for types of cancer that cannot be treated today.

13 Nov 2013

New data show positive results from Phase 4 study of Avonex Pen for treatment of RRMS patients

New data presented at the 6th Pan Asian Committee for Treatment and Research in Multiple Sclerosis, show positive preliminary results from PERSIST, a 12-month, Phase 4 clinical study of once weekly Avonex Pen for patients with relapsing-remitting multiple sclerosis.

13 Nov 2013

XTANDI now accepted for use within NHS Scotland for treatment of adult men with mCRPC

The Scottish Medicines Consortium, which advises NHS Scotland on prescribing new treatments, announced today that XTANDI (enzalutamide) is accepted for unrestricted use within NHS Scotland for the treatment of adult men with metastatic castration-resistant prostate cancer whose disease has progressed on or after docetaxel therapy.

13 Nov 2013

People suffering from chronic pain, emotional distress likely to receive long-term opioid therapy

People suffering from chronic non-cancer pain and severe emotional distress, such as depression, anxiety and substance use, are likely to receive long-term opioid therapy despite a lack of evidence that this treatment helps, reports a new review in General Hospital Psychiatry.

13 Nov 2013

Promethera Biosciences completes patient enrolment for first clinical trial of HepaStem

Promethera Biosciences, a Belgian biotechnology company developing Promethera HepaStem, a cell-based therapy for the treatment of liver-based metabolic diseases including Crigler-Najjar Syndrome and Urea Cycle Disorders, announces today the completion of patient enrolment for its first clinical trial.

12 Nov 2013

University of Sydney lecture to focus on the minds of teenage girls

Imagine a classroom of normal healthy teenage girls. As many as half of them may grow up and develop anxiety and depression. But which ones will they be?

12 Nov 2013

Therapy News and Research

TAILORED-Treatment project to increase effectiveness of antibiotics receives EU funding

Cedars-Sinai Phase I-II clinical trial may help combat recurrence of small cell lung cancer

Will Healthcare.gov troubles slow Medicaid expansion too?

Hormone therapy does not help menopausal women who do not have hot flashes

Polymer for mending broken bones holds hope for delivering chemotherapy drugs to the brain

Mount Sinai researchers successfully test SUMO-1 gene therapy to reverse heart failure

High-power blue laser gadgets can cause serious eye damage

Study shows that geranylgeraniol suppresses viability of human DU145 prostate carcinoma cells

OvaScience reports net loss of $6.9 million in Q3 2013

Imbruvica gets FDA approval for treatment of mantle cell lymphoma

TopPac® 20 ml prefillable polymer syringe for infusion therapy introduced by SCHOTT

Tailored doses of pre-transplant drug therapy in Glaucomatous patients boosts survival rates to over 90%

Welch Allyn, Cerner to deliver connected solution for patient data management

New biomedical instrument anticipated to help breakthroughs in animal, human health

Professor receives NOK 75M grant to develop idea for next generation personalized cancer therapy

New data show positive results from Phase 4 study of Avonex Pen for treatment of RRMS patients

XTANDI now accepted for use within NHS Scotland for treatment of adult men with mCRPC

People suffering from chronic pain, emotional distress likely to receive long-term opioid therapy

Promethera Biosciences completes patient enrolment for first clinical trial of HepaStem

University of Sydney lecture to focus on the minds of teenage girls

Industry Focus eBook - Life Science Microscopy (2nd Edition) eBook

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News